HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pumpless Lung Assist as a Bridge to Medical Therapy in a Teenager With Pulmonary Arterial Hypertension and Partial Anomalous Pulmonary Venous Return.

Abstract
Heart failure is the main cause of death in patients with pulmonary arterial hypertension and congenital heart disease. We used an original approach in a 15-year-old girl with rapidly progressive right heart failure secondary to severe pulmonary arterial hypertension and partial anomalous pulmonary venous return. After surgical congenital heart defect repair on cardiopulmonary bypass, she was weaned off bypass using a central Novalung for 11 days, then started on triple specific pulmonary vasodilator therapy.
AuthorsSébastien Hascoet, Angèle Boet, Régine Roussin, Julien Guihaire, Laurent Savale, Olaf Mercier, Elie Fadel
JournalThe Canadian journal of cardiology (Can J Cardiol) Vol. 36 Issue 11 Pg. 1831.e7-1831.e9 (11 2020) ISSN: 1916-7075 [Electronic] England
PMID32512141 (Publication Type: Case Reports, Research Support, Non-U.S. Gov't, Video-Audio Media)
CopyrightCopyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Female
  • Humans
  • Lung Transplantation
  • Preoperative Care (methods)
  • Pulmonary Arterial Hypertension (complications, therapy)
  • Scimitar Syndrome (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: